NCT04541082 2025-12-18Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsJazz PharmaceuticalsPhase 1 Recruiting102 enrolled
NCT06161974 2025-02-21Study of Olutasidenib and Temozolomide in HGGRigel PharmaceuticalsPhase 2 Recruiting60 enrolled